Envoy Medical (COCH) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
2 Sep, 2026Executive summary
Special meeting scheduled for October 12, 2026, at 9:00 AM Central Time in White Bear Lake, MN.
Record date for voting eligibility set as August 19, 2026.
Shareholders encouraged to review proxy materials online and vote electronically or request paper copies.
Voting matters and shareholder proposals
Proposal to approve an amendment allowing the Board to effect one or more reverse stock splits of Class A Common Stock at a ratio between 1-for-5 and 1-for-25, any time before December 31, 2026.
Proposal to approve adjournment(s) of the meeting if more time is needed to solicit proxies or achieve quorum.
Board recommends voting 'FOR' all proposals.
Board of directors and corporate governance
Board of Directors holds discretion to implement the reverse stock split within the specified range and timeframe.
Latest events from Envoy Medical
- Shareholders will vote on a reverse stock split to maintain Nasdaq listing and enhance liquidity.COCH
Proxy filing - Vote on a reverse stock split to maintain Nasdaq listing and enhance stock liquidity.COCH
Proxy filing - Fully implanted cochlear implant aims to disrupt a $84B market with FDA approval expected in 2027.COCH
Investor presentation - Q2 2026 net loss was $5.98M; Acclaim CI trial fully enrolled, PMA submitted, and IP expanded.COCH
Q2 2026 - Fully implanted cochlear implant nears FDA submission, aiming to disrupt a $84B U.S. market.COCH
Life Sciences Virtual Investor Forum - Fully implanted cochlear implant advances toward FDA approval, targeting a vast unmet market.COCH
Investor presentation - Offering up to 47.2M shares and warrants to fund clinical trials for a novel cochlear implant.COCH
Registration filing - Pre-revenue, high-risk hearing device innovator with major funding needs and regulatory hurdles.COCH
Registration filing - Pre-revenue, high-risk hearing device innovator targeting a large market, pending FDA approval.COCH
Registration filing